Gin Hwa Biotech (7806) reported revenue of NT$35.7 million for Oct 2026, -9.0% year on year and -25.3% from the previous month. Revenue for Jan–Oct 2026 was NT$455.3 million (+3.1% year on year).
In Oct 2026, it ranked No. 32 by revenue among 34 Food companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$35.7 million | -9.0% | -25.3% |
| Sep 2026 | NT$47.7 million | +41.5% | +4.4% |
| Aug 2026 | NT$45.7 million | -8.6% | +3.8% |
| Jul 2026 | NT$44 million | +27.0% | -9.8% |
| Jun 2026 | NT$48.8 million | +13.5% | +0.9% |
| May 2026 | NT$48.4 million | -0.7% | -1.2% |
| Apr 2026 | NT$49 million | +12.6% | -11.6% |
| Mar 2026 | NT$55.4 million | -29.0% | +63.8% |
| Feb 2026 | NT$33.8 million | -7.9% | -27.7% |
| Jan 2026 | NT$46.8 million | +37.1% | -4.7% |
| Dec 2025 | NT$49.1 million | +16.9% | +2.9% |
| Nov 2025 | NT$47.8 million | +29.1% | +21.8% |
| Oct 2025 | NT$39.2 million | +14.3% | +16.3% |
| Sep 2025 | NT$33.7 million | +4.3% | -32.5% |
| Aug 2025 | NT$50 million | +36.7% | +44.2% |
| Jul 2025 | NT$34.6 million | -17.8% | -19.5% |
| Jun 2025 | NT$43 million | +62.3% | -11.7% |
| May 2025 | NT$48.7 million | +33.2% | +12.0% |
| Apr 2025 | NT$43.5 million | +39.2% | -44.3% |
| Mar 2025 | NT$78.1 million | +56.8% | +112.5% |
| Feb 2025 | NT$36.7 million | +49.1% | +7.6% |
| Jan 2025 | NT$34.1 million | -18.8% | -18.8% |
| Dec 2024 | NT$42 million | +26.1% | +13.6% |
| Nov 2024 | NT$37 million | +12.6% | +7.9% |
| Oct 2024 | NT$34.3 million | — | +6.1% |
Jan–Oct 2026 cumulative: NT$455.3 million (+3.1% YoY)
Other Food companies
Compare with peers: Gin Hwa Biotech vs UNI-PRESIDENT / Gin Hwa Biotech vs GREATWALL / Gin Hwa Biotech vs CPE
| Company | Revenue | YoY |
|---|---|---|
| UNI-PRESIDENT | NT$57.1 billion | +5.3% |
| GREATWALL | NT$9.66 billion | +14.6% |
| CPE | NT$2.66 billion | +13.4% |
| TTET | NT$2.48 billion | +33.4% |
| SFC | NT$2.08 billion | -3.5% |
| WEI CHUAN | NT$1.88 billion | +4.4% |
| NAMCHOW | NT$1.87 billion | +3.1% |
| LHIHC | NT$1.1 billion | +8.0% |
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16